. 2017 Nov 10;7:15279. doi: 10.1038/s41598-017-13148-y

Table 3.

Comparison of antimicrobial susceptibilities of Acinetobacter baumannii from BP and NBP groups.

Antimicrobial agent	BP		NBP		X²	P value
Antimicrobial agent	R%	MIC₅₀/MIC₉₀	R%	MIC₅₀/MIC₉₀	X²	P value
cefepime	95.35	64/≥128	92.13	64/≥128	0.767	0.381
ceftriaxone	96.51	≥128/≥128	91.01	≥128/≥128	2.246	0.134
ciprofloxacin	95.35	≥16/≥16	95.51	≥16/≥16	0.002	0.960
imipenem	95.35	32/≥128	91.01	16/≥128	1.288	0.256
piperacillin/tazobactam	96.51	≥512/4/≥512/4	89.89	256/4/≥512/4	3.005	0.083
gentamicin	89.53	32/≥128	93.26	32/≥128	0.774	0.379
tobramycin	87.21	32/≥128	86.52	32/≥128	0.018	0.892
levofloxacin	55.81	8/≥32	56.18	8/≥32	0.002	0.961
tigecycline	22.09	1/4	15.73	1/4	1.157	0.282
cefperazone/sulbactam	87.21	64/≥256	84.27	64/≥256	0.309	0.579
minocyline	51.28	8/32	53.85	16/32	1.799	0.180
amikacin	65.63	128/≥512	69.64	128/≥512	0.152	0.697
ceftazidime	96.51	≥128/≥128	95.51	≥128/≥128	0.115	0.734
ampicillin/sulbactam	94.19	128/≥512	95.51	128/≥512	0.156	0.693
meropenem	95.35	≥32/≥32	93.26	16/≥32	0.355	0.551
polymyxin B	3.49	2/2	3.37	2/2	0.002	0.966